nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—SLCO1B3—Methotrexate—bone cancer	0.113	0.146	CbGbCtD
Telmisartan—ABCC2—Carboplatin—bone cancer	0.104	0.135	CbGbCtD
Telmisartan—ABCG2—Carboplatin—bone cancer	0.0941	0.122	CbGbCtD
Telmisartan—ABCC2—Cisplatin—bone cancer	0.0889	0.115	CbGbCtD
Telmisartan—ABCG2—Cisplatin—bone cancer	0.0804	0.104	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—bone cancer	0.0596	0.0773	CbGbCtD
Telmisartan—ABCC2—Methotrexate—bone cancer	0.0577	0.0749	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—bone cancer	0.0539	0.0699	CbGbCtD
Telmisartan—ABCG2—Methotrexate—bone cancer	0.0522	0.0677	CbGbCtD
Telmisartan—ABCB1—Cisplatin—bone cancer	0.029	0.0376	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—bone cancer	0.0194	0.0252	CbGbCtD
Telmisartan—ABCB1—Methotrexate—bone cancer	0.0188	0.0244	CbGbCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.00347	0.0646	CbGpPWpGaD
Telmisartan—PPARG—periosteum—bone cancer	0.00301	0.2	CbGeAlD
Telmisartan—Deferasirox—CYP3A4—bone cancer	0.00285	0.807	CrCbGaD
Telmisartan—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00251	0.0467	CbGpPWpGaD
Telmisartan—PPARG—leg—bone cancer	0.0024	0.159	CbGeAlD
Telmisartan—PPARG—forelimb—bone cancer	0.00238	0.158	CbGeAlD
Telmisartan—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00235	0.0438	CbGpPWpGaD
Telmisartan—PPARG—hindlimb—bone cancer	0.00214	0.142	CbGeAlD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00204	0.038	CbGpPWpGaD
Telmisartan—PPARG—appendage—bone cancer	0.00184	0.122	CbGeAlD
Telmisartan—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00161	0.03	CbGpPWpGaD
Telmisartan—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.00161	0.0299	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors—NR1I2—bone cancer	0.00148	0.0274	CbGpPWpGaD
Telmisartan—ABCG2—Irinotecan Pathway—CYP3A4—bone cancer	0.0014	0.026	CbGpPWpGaD
Telmisartan—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00138	0.0256	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—GNA11—bone cancer	0.00136	0.0253	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00135	0.0251	CbGpPWpGaD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00121	0.0224	CbGpPWpGaD
Telmisartan—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00118	0.022	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00117	0.0217	CbGpPWpGaD
Telmisartan—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00111	0.0206	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.0011	0.0205	CbGpPWpGaD
Telmisartan—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000942	0.0175	CbGpPWpGaD
Telmisartan—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.00083	0.0154	CbGpPWpGaD
Telmisartan—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000829	0.0154	CbGpPWpGaD
Telmisartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00079	0.0147	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—MET—bone cancer	0.000767	0.0142	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000741	0.0138	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—bone cancer	0.000692	0.0129	CbGpPWpGaD
Telmisartan—Losartan—CYP3A4—bone cancer	0.00068	0.193	CrCbGaD
Telmisartan—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000647	0.012	CbGpPWpGaD
Telmisartan—AGTR1—connective tissue—bone cancer	0.000638	0.0423	CbGeAlD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000636	0.0118	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—ZNF77—bone cancer	0.000595	0.0111	CbGpPWpGaD
Telmisartan—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000582	0.0108	CbGpPWpGaD
Telmisartan—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.00056	0.0104	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—GRM1—bone cancer	0.000554	0.0103	CbGpPWpGaD
Telmisartan—PPARG—connective tissue—bone cancer	0.000525	0.0348	CbGeAlD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000519	0.00964	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000495	0.00921	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—bone cancer	0.000481	0.00893	CbGpPWpGaD
Telmisartan—AGTR1—tendon—bone cancer	0.000439	0.0291	CbGeAlD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.000429	0.00797	CbGpPWpGaD
Telmisartan—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000399	0.00742	CbGpPWpGaD
Telmisartan—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00039	0.00725	CbGpPWpGaD
Telmisartan—AGTR1—Arf6 signaling events—EGFR—bone cancer	0.000388	0.00722	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000371	0.0069	CbGpPWpGaD
Telmisartan—PPARG—tendon—bone cancer	0.000361	0.0239	CbGeAlD
Telmisartan—AGTR1—G alpha (q) signalling events—GNA11—bone cancer	0.000357	0.00663	CbGpPWpGaD
Telmisartan—PPARG—bone marrow—bone cancer	0.000349	0.0232	CbGeAlD
Telmisartan—PPARG—Regulation of retinoblastoma protein—MET—bone cancer	0.000344	0.00639	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDK4—bone cancer	0.000344	0.00639	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—GRM4—bone cancer	0.000322	0.00599	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000319	0.00593	CbGpPWpGaD
Telmisartan—ABCC2—tendon—bone cancer	0.000317	0.021	CbGeAlD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bone cancer	0.000307	0.0057	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—CDK4—bone cancer	0.000304	0.00564	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000299	0.00556	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—RB1—bone cancer	0.000299	0.00555	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ZNF77—bone cancer	0.000286	0.00532	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—GRM1—bone cancer	0.000279	0.00519	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000276	0.00514	CbGpPWpGaD
Telmisartan—Bronchitis—Doxorubicin—bone cancer	0.000273	0.00174	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—bone cancer	0.000269	0.00172	CcSEcCtD
Telmisartan—Body temperature increased—Cisplatin—bone cancer	0.000269	0.00172	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—bone cancer	0.000268	0.00171	CcSEcCtD
Telmisartan—Urinary tract infection—Epirubicin—bone cancer	0.000266	0.0017	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—bone cancer	0.000266	0.0017	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—bone cancer	0.000266	0.0017	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000264	0.00169	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—bone cancer	0.000263	0.00168	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—bone cancer	0.000261	0.00167	CcSEcCtD
Telmisartan—Pharyngitis—Methotrexate—bone cancer	0.000261	0.00166	CcSEcCtD
Telmisartan—Urinary tract disorder—Methotrexate—bone cancer	0.000259	0.00166	CcSEcCtD
Telmisartan—Hepatobiliary disease—Epirubicin—bone cancer	0.000259	0.00165	CcSEcCtD
Telmisartan—Epistaxis—Epirubicin—bone cancer	0.000258	0.00165	CcSEcCtD
Telmisartan—Urethral disorder—Methotrexate—bone cancer	0.000258	0.00164	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—bone cancer	0.000257	0.00164	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—bone cancer	0.000255	0.00163	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—MDM2—bone cancer	0.000255	0.00473	CbGpPWpGaD
Telmisartan—Infestation—Doxorubicin—bone cancer	0.000253	0.00162	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—bone cancer	0.000253	0.00162	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—bone cancer	0.000253	0.00162	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—GNA11—bone cancer	0.000251	0.00466	CbGpPWpGaD
Telmisartan—Hypersensitivity—Cisplatin—bone cancer	0.000251	0.0016	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—bone cancer	0.00025	0.0016	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—EZH2—bone cancer	0.00025	0.00464	CbGpPWpGaD
Telmisartan—Renal failure—Doxorubicin—bone cancer	0.000249	0.00159	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—bone cancer	0.000248	0.00159	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—bone cancer	0.000246	0.00157	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—bone cancer	0.000246	0.00157	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—bone cancer	0.000246	0.00157	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—bone cancer	0.000246	0.00157	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—bone cancer	0.000245	0.00156	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—bone cancer	0.000245	0.00156	CcSEcCtD
Telmisartan—Asthenia—Cisplatin—bone cancer	0.000244	0.00156	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—bone cancer	0.000244	0.00156	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—bone cancer	0.000244	0.00156	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—bone cancer	0.000243	0.00155	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—bone cancer	0.000242	0.00155	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—bone cancer	0.000242	0.00154	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—bone cancer	0.000242	0.00154	CcSEcCtD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000242	0.00449	CbGpPWpGaD
Telmisartan—Urethral disorder—Epirubicin—bone cancer	0.000241	0.00154	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—bone cancer	0.00024	0.00153	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—bone cancer	0.000239	0.00153	CcSEcCtD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000238	0.00443	CbGpPWpGaD
Telmisartan—Angiopathy—Methotrexate—bone cancer	0.000238	0.00152	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—bone cancer	0.000238	0.00152	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—bone cancer	0.000237	0.00151	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—bone cancer	0.000237	0.00151	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—bone cancer	0.000237	0.00151	CcSEcCtD
Telmisartan—Chills—Methotrexate—bone cancer	0.000236	0.0015	CcSEcCtD
Telmisartan—Diarrhoea—Cisplatin—bone cancer	0.000233	0.00149	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—bone cancer	0.000232	0.00148	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000231	0.0043	CbGpPWpGaD
Telmisartan—Mental disorder—Methotrexate—bone cancer	0.00023	0.00147	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—bone cancer	0.00023	0.00147	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—bone cancer	0.000229	0.00146	CcSEcCtD
Telmisartan—Erythema—Methotrexate—bone cancer	0.000229	0.00146	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—bone cancer	0.000229	0.00146	CcSEcCtD
Telmisartan—Flushing—Epirubicin—bone cancer	0.000228	0.00146	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—bone cancer	0.000228	0.00146	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—bone cancer	0.000228	0.00146	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—bone cancer	0.000226	0.00144	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—bone cancer	0.000226	0.00144	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—bone cancer	0.000225	0.00143	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—bone cancer	0.000224	0.00143	CcSEcCtD
Telmisartan—ABCG2—bone marrow—bone cancer	0.000224	0.0149	CbGeAlD
Telmisartan—Dysgeusia—Methotrexate—bone cancer	0.000224	0.00143	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—bone cancer	0.000224	0.00143	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—bone cancer	0.000223	0.00142	CcSEcCtD
Telmisartan—ABCG2—spinal cord—bone cancer	0.000223	0.0148	CbGeAlD
Telmisartan—Urethral disorder—Doxorubicin—bone cancer	0.000223	0.00142	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—bone cancer	0.000222	0.00142	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—bone cancer	0.000222	0.00141	CcSEcCtD
Telmisartan—PPARG—Regulation of retinoblastoma protein—JUN—bone cancer	0.000221	0.00411	CbGpPWpGaD
Telmisartan—Back pain—Methotrexate—bone cancer	0.000221	0.00141	CcSEcCtD
Telmisartan—Chills—Epirubicin—bone cancer	0.000221	0.00141	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—bone cancer	0.00022	0.0014	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—bone cancer	0.000219	0.0014	CcSEcCtD
Telmisartan—Vomiting—Cisplatin—bone cancer	0.000216	0.00138	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—bone cancer	0.000215	0.00137	CcSEcCtD
Telmisartan—Rash—Cisplatin—bone cancer	0.000214	0.00137	CcSEcCtD
Telmisartan—Dermatitis—Cisplatin—bone cancer	0.000214	0.00137	CcSEcCtD
Telmisartan—Erythema—Epirubicin—bone cancer	0.000214	0.00137	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—bone cancer	0.000214	0.00137	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—bone cancer	0.000213	0.00136	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—bone cancer	0.000212	0.00135	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—bone cancer	0.000212	0.00135	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—bone cancer	0.000211	0.00135	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—bone cancer	0.000211	0.00135	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—bone cancer	0.000211	0.00135	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—bone cancer	0.000211	0.00135	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000211	0.00391	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000211	0.00391	CbGpPWpGaD
Telmisartan—Tension—Epirubicin—bone cancer	0.00021	0.00134	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—bone cancer	0.00021	0.00134	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—bone cancer	0.000208	0.00133	CcSEcCtD
Telmisartan—Back pain—Epirubicin—bone cancer	0.000207	0.00132	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—bone cancer	0.000206	0.00132	CcSEcCtD
Telmisartan—Malaise—Methotrexate—bone cancer	0.000206	0.00132	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—bone cancer	0.000206	0.00131	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—bone cancer	0.000205	0.00131	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—bone cancer	0.000205	0.00131	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—bone cancer	0.000205	0.00131	CcSEcCtD
Telmisartan—Chills—Doxorubicin—bone cancer	0.000204	0.0013	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—bone cancer	0.000203	0.0013	CcSEcCtD
Telmisartan—Nausea—Cisplatin—bone cancer	0.000202	0.00129	CcSEcCtD
Telmisartan—PPARG—Generic Transcription Pathway—NR1I2—bone cancer	0.000201	0.00374	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.0002	0.00371	CbGpPWpGaD
Telmisartan—Cough—Methotrexate—bone cancer	0.0002	0.00127	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—bone cancer	0.000199	0.00127	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—bone cancer	0.000199	0.00127	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—bone cancer	0.000198	0.00126	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—bone cancer	0.000198	0.00126	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—bone cancer	0.000198	0.00126	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—SMO—bone cancer	0.000197	0.00366	CbGpPWpGaD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000196	0.00364	CbGpPWpGaD
Telmisartan—Flatulence—Doxorubicin—bone cancer	0.000195	0.00125	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—bone cancer	0.000195	0.00124	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—bone cancer	0.000195	0.00124	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—bone cancer	0.000195	0.00124	CcSEcCtD
Telmisartan—Tension—Doxorubicin—bone cancer	0.000194	0.00124	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—bone cancer	0.000194	0.00124	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000193	0.00123	CcSEcCtD
Telmisartan—Malaise—Epirubicin—bone cancer	0.000193	0.00123	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—bone cancer	0.000192	0.00123	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—bone cancer	0.000192	0.00123	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—bone cancer	0.000192	0.00123	CcSEcCtD
Telmisartan—Syncope—Epirubicin—bone cancer	0.000192	0.00122	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—bone cancer	0.000192	0.00122	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—bone cancer	0.00019	0.00121	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—bone cancer	0.000189	0.00121	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—bone cancer	0.000188	0.0012	CcSEcCtD
Telmisartan—Cough—Epirubicin—bone cancer	0.000187	0.00119	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—bone cancer	0.000187	0.00119	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.000186	0.00345	CbGpPWpGaD
Telmisartan—Infection—Methotrexate—bone cancer	0.000185	0.00118	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—bone cancer	0.000185	0.00118	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—bone cancer	0.000184	0.00117	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—bone cancer	0.000183	0.00117	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—bone cancer	0.000183	0.00117	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—bone cancer	0.000183	0.00117	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—bone cancer	0.000182	0.00116	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—bone cancer	0.000182	0.00116	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—bone cancer	0.000182	0.00116	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—GRM4—bone cancer	0.000182	0.00338	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—RGS1—bone cancer	0.000182	0.00338	CbGpPWpGaD
Telmisartan—Anxiety—Epirubicin—bone cancer	0.000182	0.00116	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—bone cancer	0.000181	0.00116	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000181	0.00115	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—NDUFA12—bone cancer	0.000181	0.00336	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Methotrexate—bone cancer	0.00018	0.00115	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—bone cancer	0.00018	0.00115	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—bone cancer	0.000179	0.00114	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—bone cancer	0.000178	0.00114	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—bone cancer	0.000178	0.00114	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—bone cancer	0.000178	0.00114	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—bone cancer	0.000178	0.00113	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—bone cancer	0.000175	0.00112	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—bone cancer	0.000175	0.00111	CcSEcCtD
Telmisartan—Oedema—Epirubicin—bone cancer	0.000175	0.00111	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—bone cancer	0.000174	0.00111	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—bone cancer	0.000174	0.00111	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—RB1—bone cancer	0.000174	0.00323	CbGpPWpGaD
Telmisartan—Infection—Epirubicin—bone cancer	0.000174	0.00111	CcSEcCtD
Telmisartan—Cough—Doxorubicin—bone cancer	0.000173	0.0011	CcSEcCtD
Telmisartan—Shock—Epirubicin—bone cancer	0.000172	0.0011	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—bone cancer	0.000171	0.00109	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—bone cancer	0.000171	0.00109	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—bone cancer	0.000171	0.00109	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—bone cancer	0.00017	0.00109	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00017	0.00109	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—bone cancer	0.00017	0.00108	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—bone cancer	0.000169	0.00108	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—bone cancer	0.000169	0.00108	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—bone cancer	0.000169	0.00108	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—bone cancer	0.000169	0.00108	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—bone cancer	0.000169	0.00108	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—bone cancer	0.000168	0.00107	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—bone cancer	0.000168	0.00107	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000167	0.00107	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—bone cancer	0.000167	0.00106	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—bone cancer	0.000167	0.00106	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—bone cancer	0.000166	0.00106	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—bone cancer	0.000166	0.00106	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000166	0.00308	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GRM4—bone cancer	0.000165	0.00307	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RGS1—bone cancer	0.000165	0.00307	CbGpPWpGaD
Telmisartan—Dry mouth—Doxorubicin—bone cancer	0.000165	0.00105	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—bone cancer	0.000164	0.00105	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—bone cancer	0.000163	0.00104	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—bone cancer	0.000162	0.00104	CcSEcCtD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000162	0.00301	CbGpPWpGaD
Telmisartan—Oedema—Doxorubicin—bone cancer	0.000162	0.00103	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—bone cancer	0.000162	0.00103	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000161	0.003	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Methotrexate—bone cancer	0.000161	0.00103	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—bone cancer	0.000161	0.00103	CcSEcCtD
Telmisartan—Infection—Doxorubicin—bone cancer	0.000161	0.00102	CcSEcCtD
Telmisartan—Pain—Methotrexate—bone cancer	0.00016	0.00102	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000159	0.00102	CcSEcCtD
Telmisartan—Shock—Doxorubicin—bone cancer	0.000159	0.00101	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—bone cancer	0.000159	0.00101	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—bone cancer	0.000158	0.00101	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—bone cancer	0.000158	0.00101	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—GRM1—bone cancer	0.000158	0.00293	CbGpPWpGaD
Telmisartan—Tachycardia—Doxorubicin—bone cancer	0.000158	0.00101	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—bone cancer	0.000157	0.001	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—bone cancer	0.000157	0.001	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—bone cancer	0.000156	0.000997	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—bone cancer	0.000156	0.000994	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—bone cancer	0.000155	0.000991	CcSEcCtD
Telmisartan—PPARG—Metabolism—NDUFA12—bone cancer	0.000154	0.00287	CbGpPWpGaD
Telmisartan—Anorexia—Doxorubicin—bone cancer	0.000154	0.000983	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—bone cancer	0.000154	0.000982	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—bone cancer	0.000154	0.000981	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—bone cancer	0.000153	0.000974	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—bone cancer	0.000152	0.000969	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—bone cancer	0.000151	0.000964	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—bone cancer	0.000151	0.000962	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—bone cancer	0.000151	0.000961	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—NT5C3A—bone cancer	0.00015	0.00279	CbGpPWpGaD
Telmisartan—Constipation—Epirubicin—bone cancer	0.000149	0.000953	CcSEcCtD
Telmisartan—Pain—Epirubicin—bone cancer	0.000149	0.000953	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—bone cancer	0.000148	0.000946	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—bone cancer	0.000148	0.000942	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—bone cancer	0.000148	0.000942	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000147	0.00094	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—bone cancer	0.000146	0.000933	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—bone cancer	0.000145	0.000926	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—bone cancer	0.000144	0.000919	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000144	0.00268	CbGpPWpGaD
Telmisartan—Feeling abnormal—Epirubicin—bone cancer	0.000144	0.000919	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—bone cancer	0.000144	0.000917	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—GRM1—bone cancer	0.000143	0.00266	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000143	0.00266	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Epirubicin—bone cancer	0.000143	0.000911	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—bone cancer	0.000142	0.000908	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—CDK4—bone cancer	0.000141	0.00262	CbGpPWpGaD
Telmisartan—Decreased appetite—Doxorubicin—bone cancer	0.000141	0.000897	CcSEcCtD
Telmisartan—PPARG—Gene Expression—FUS—bone cancer	0.00014	0.0026	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00014	0.00089	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—bone cancer	0.000139	0.000889	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—bone cancer	0.000139	0.000885	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—bone cancer	0.000138	0.000882	CcSEcCtD
Telmisartan—Pain—Doxorubicin—bone cancer	0.000138	0.000882	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—bone cancer	0.000138	0.000881	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—bone cancer	0.000138	0.000881	CcSEcCtD
Telmisartan—Hypersensitivity—Methotrexate—bone cancer	0.000138	0.000878	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—bone cancer	0.000134	0.000855	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—bone cancer	0.000133	0.00085	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000132	0.00246	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Doxorubicin—bone cancer	0.000132	0.000843	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—bone cancer	0.000132	0.000843	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—bone cancer	0.000129	0.000821	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—bone cancer	0.000128	0.000819	CcSEcCtD
Telmisartan—PPARG—Metabolism—NT5C3A—bone cancer	0.000128	0.00238	CbGpPWpGaD
Telmisartan—Abdominal pain—Doxorubicin—bone cancer	0.000128	0.000815	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—bone cancer	0.000128	0.000815	CcSEcCtD
Telmisartan—Diarrhoea—Methotrexate—bone cancer	0.000128	0.000815	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—bone cancer	0.000125	0.0008	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000124	0.00231	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000124	0.0023	CbGpPWpGaD
Telmisartan—Pruritus—Epirubicin—bone cancer	0.000124	0.000789	CcSEcCtD
Telmisartan—Dizziness—Methotrexate—bone cancer	0.000123	0.000788	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—bone cancer	0.00012	0.000763	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—bone cancer	0.000119	0.00076	CcSEcCtD
Telmisartan—Vomiting—Methotrexate—bone cancer	0.000119	0.000757	CcSEcCtD
Telmisartan—Rash—Methotrexate—bone cancer	0.000118	0.000751	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—bone cancer	0.000118	0.00075	CcSEcCtD
Telmisartan—Headache—Methotrexate—bone cancer	0.000117	0.000746	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—bone cancer	0.000116	0.00074	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—bone cancer	0.000116	0.000737	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—bone cancer	0.000114	0.00073	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000113	0.00209	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NDUFA12—bone cancer	0.000113	0.00209	CbGpPWpGaD
Telmisartan—Vomiting—Epirubicin—bone cancer	0.000111	0.000709	CcSEcCtD
Telmisartan—Nausea—Methotrexate—bone cancer	0.000111	0.000707	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—bone cancer	0.000111	0.000706	CcSEcCtD
Telmisartan—ABCB1—bone marrow—bone cancer	0.00011	0.00733	CbGeAlD
Telmisartan—Rash—Epirubicin—bone cancer	0.00011	0.000703	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—bone cancer	0.00011	0.000702	CcSEcCtD
Telmisartan—ABCB1—spinal cord—bone cancer	0.00011	0.0073	CbGeAlD
Telmisartan—Headache—Epirubicin—bone cancer	0.000109	0.000698	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—bone cancer	0.000107	0.000682	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000104	0.00193	CbGpPWpGaD
Telmisartan—Nausea—Epirubicin—bone cancer	0.000104	0.000662	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—bone cancer	0.000103	0.000656	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000103	0.00191	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000103	0.00191	CbGpPWpGaD
Telmisartan—Rash—Doxorubicin—bone cancer	0.000102	0.00065	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—bone cancer	0.000102	0.00065	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—GNA11—bone cancer	0.000102	0.00189	CbGpPWpGaD
Telmisartan—Headache—Doxorubicin—bone cancer	0.000101	0.000646	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—SMO—bone cancer	0.000101	0.00188	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GRM4—bone cancer	9.77e-05	0.00182	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RGS1—bone cancer	9.77e-05	0.00182	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NR1I2—bone cancer	9.7e-05	0.0018	CbGpPWpGaD
Telmisartan—Nausea—Doxorubicin—bone cancer	9.6e-05	0.000613	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.34e-05	0.00174	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NT5C3A—bone cancer	9.33e-05	0.00173	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—GNA11—bone cancer	9.24e-05	0.00172	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL3—bone cancer	9.22e-05	0.00171	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.21e-05	0.00171	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	9.09e-05	0.00169	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—JUN—bone cancer	9.08e-05	0.00169	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.9e-05	0.00165	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.78e-05	0.00163	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.73e-05	0.00162	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GRM1—bone cancer	8.47e-05	0.00157	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL3—bone cancer	8.37e-05	0.00156	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.81e-05	0.00145	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.78e-05	0.00145	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—EIF2S1—bone cancer	7.16e-05	0.00133	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MET—bone cancer	6.87e-05	0.00128	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CDK4—bone cancer	6.87e-05	0.00128	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.72e-05	0.00125	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ENO2—bone cancer	6.57e-05	0.00122	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NDUFA12—bone cancer	6.24e-05	0.00116	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—EZH2—bone cancer	6.22e-05	0.00116	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—DHFR—bone cancer	6.09e-05	0.00113	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NDUFA12—bone cancer	6.09e-05	0.00113	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—bone cancer	6e-05	0.00111	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SMO—bone cancer	5.97e-05	0.00111	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.79e-05	0.00108	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP2—bone cancer	5.73e-05	0.00106	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GNA11—bone cancer	5.69e-05	0.00106	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ENO2—bone cancer	5.6e-05	0.00104	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GNA11—bone cancer	5.46e-05	0.00101	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—DHFR—bone cancer	5.2e-05	0.000966	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NT5C3A—bone cancer	5.17e-05	0.00096	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP3A4—bone cancer	5.16e-05	0.000959	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.14e-05	0.000955	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ATF1—bone cancer	5.07e-05	0.000943	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NT5C3A—bone cancer	5.04e-05	0.000937	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL3—bone cancer	4.95e-05	0.000919	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GNA11—bone cancer	4.86e-05	0.000903	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTP1—bone cancer	4.42e-05	0.000821	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP3A4—bone cancer	4.41e-05	0.000819	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.38e-05	0.000814	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—bone cancer	4.3e-05	0.0008	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.29e-05	0.000798	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFBR2—bone cancer	4.23e-05	0.000786	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.14e-05	0.000769	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ENO2—bone cancer	4.09e-05	0.000759	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1R—bone cancer	3.98e-05	0.00074	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—DHFR—bone cancer	3.79e-05	0.000704	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—bone cancer	3.77e-05	0.0007	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.73e-05	0.000693	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNA11—bone cancer	3.54e-05	0.000658	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—bone cancer	3.48e-05	0.000646	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP3A4—bone cancer	3.21e-05	0.000597	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.93e-05	0.000545	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KIT—bone cancer	2.89e-05	0.000537	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—bone cancer	2.75e-05	0.00051	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—bone cancer	2.71e-05	0.000504	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—bone cancer	2.63e-05	0.000489	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.46e-05	0.000458	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—bone cancer	2.29e-05	0.000425	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MDM2—bone cancer	2.27e-05	0.000423	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO2—bone cancer	2.26e-05	0.000421	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO2—bone cancer	2.21e-05	0.000411	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—DHFR—bone cancer	2.1e-05	0.00039	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—DHFR—bone cancer	2.05e-05	0.000381	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—bone cancer	1.98e-05	0.000367	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNA11—bone cancer	1.96e-05	0.000365	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—bone cancer	1.95e-05	0.000363	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—bone cancer	1.92e-05	0.000357	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNA11—bone cancer	1.92e-05	0.000356	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP3A4—bone cancer	1.78e-05	0.000331	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.77e-05	0.000329	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP3A4—bone cancer	1.74e-05	0.000323	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—bone cancer	1.55e-05	0.000289	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—bone cancer	1.52e-05	0.000283	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—bone cancer	1.49e-05	0.000276	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—bone cancer	1.42e-05	0.000264	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—bone cancer	1.3e-05	0.000242	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—bone cancer	7.88e-06	0.000146	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—bone cancer	7.69e-06	0.000143	CbGpPWpGaD
